Agree with you on all the points. If AUPH result is not good enough in August, then the stock will be 0 as they have no money. It is not going to be down -60% or -70%. IMO, new management have not raised money because they have no choice but to wait for P2b result to get some decent term as biotech financing is quite difficult lately (companies have to settle for low end share price for IPO if they could even get the opportunity for IPO, private placement to raise money, etc.). That said, quite a few think the odds of success are pretty good. Just don't bet the farm on it.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.